SAENGER BRADLEY (Chief Financial Officer) reported 1 transaction at TONIX PHARMACEUTICALS HOLDING CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 7/9/2026ACC: 0001493152-26-032615
Officer· Chief Financial Officer
Since Feb 2026
+1.45K
Net shares
Net buyer
$15.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.45K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+1.45K
Price / share
$10.91
Trade value
$15.86K
% of position
207.3%
6/30/2026
701.00→2.15K
Total
Net shares
+1.45K
Net value
$15.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 6/30/2026 | J · J | +1.45K | $10.91 | $15.86K | 207.3% | 701.00 | 2.15K |
| Total | +1.45K | $15.86K | ||||||
Derivative Transactions0
No derivative transactions reported